HypernatremiaMANAGEMENT

ENDOCRINE AND METABOLIC PRESENTATIONS · 12 SECTIONS

⚲

667 items

☷ Legend

⚲

Cardiovascular Presentations71▾

Respiratory Presentations52▾

Neurological Presentations83▾

Gastrointestinal Presentations74▾

Genitourinary and Reproductive Presentations48▾

Infectious Disease Presentations148▾

Trauma Presentations89▾

Toxicologic Presentations80▾

Psychiatric Presentations26▾

Musculoskeletal and Rheumatologic Presentations96▾

Dermatology Presentations23▾

Environmental and Exposure Presentations27▾

Hematologic and Oncologic Presentations36▾

Pediatric-Specific Presentations19▾

Endocrine and Metabolic Presentations45▾

Acute Porphyria Adrenal crisis Adrenal Insufficiency (Addisonian Crisis)Dehydration Diabetes Insipidus Diabetic Ketoacidosis (DKA)Euglycemic DKA (SGLT2 inhibitor)Galactosemia GLP-1 receptor agonist complications (retained gastric contents, aspiration risk)Homocystinuria Hypercalcemia Hyperkalemia Hypermagnesemia Hypernatremia Hyperosmolar Hyperglycemic State (HHS)Hypertensive emergency Hypertensive urgency Hypocalcemia Hypoglycemia Hypogonadism (Acute Presentation)Hypokalemia Hypomagnesemia Hyponatremia Hypoparathyroidism (Tetany)Insulin pump failure Maple Syrup Urine Disease (Crisis)Medium-Chain Acyl-CoA Dehydrogenase Deficiency (MCAD)Metabolic Acidosis Metabolic Alkalosis Myasthenia gravis crisis Myxedema coma Pellagra Pheochromocytoma (Crisis)Pituitary Apoplexy Pompe Disease (GSD II)Respiratory Acidosis Respiratory Alkalosis Scurvy SIADH Starvation Ketosis Tarui Disease (GSD VII)Thyroid storm Tyrosinemia Vitamin D Deficiency (Severe-Rickets)Von Gierke Disease (GSD I)

ENT and Maxillofacial Presentations27▾

Ophthalmologic Presentations19▾

Obstetric Presentations23▾

Systemic and Miscellaneous Presentations17▾

01Approach to the Critical Patient/attcp50

Immediate priorities

›Airway and mental status threats

›Altered mental status

›Lethargy or obtundation with Na > 155 mmol/l

›Coma or seizures with Na > 160 mmol/l

›Airway protection threshold

›GCS < 8 warrants intubation consideration

›Aspiration risk in obtunded patients

›Immediate IV access and cardiac monitoring for severe cases

›Na >= 160 mmol/l triggers resuscitation bay

›Continuous pulse oximetry

›Hemodynamic assessment

›Volume status classification

›Hypovolemic hypernatremia — most common

›Euvolemic hypernatremia — insensible or renal losses

›Hypervolemic hypernatremia — iatrogenic sodium loading

›Shock physiology

›SBP < 90 mmHg

›MAP < 65 mmHg

›HR > 100 with orthostatic drop

›If hemodynamic instability, isotonic saline first to restore perfusion before free water correction

Monitoring and targets

›Monitoring bundle

›Serum sodium every 4 to 6 hours during active correction

›Target correction rate <= 10 mmol/l per 24 hours for chronic hypernatremia

›Acute hypernatremia (<48 hours) can be corrected at up to 1 mmol/l per hour

›Urine output hourly in severe cases

›Target > 0.5 ml/kg/hour

02History/hx62

Presentation pattern

›Core symptoms

›Neurologic symptoms

›Lethargy, weakness, irritability

›Confusion or agitation

›Seizures or coma in severe cases

›Fluid intake history

›Access to water impaired

›Thirst perception absent or reduced

›Volume of oral intake over preceding days

›Fluid losses

›Diarrhea or vomiting

›Polyuria with dilute urine

›Excessive sweating or fever-related losses

›Burns

Onset and chronicity

›Timing classification

›Acute onset — less than 48 hours

›Risk of cerebral hemorrhage from brain shrinkage

›Permits faster correction rate

›Chronic or unknown onset — greater than 48 hours

›Brain has accumulated idiogenic osmoles

›Rapid correction risks cerebral edema

›Iatrogenic and in-hospital onset

›Recent IV fluids with high sodium content

›Concentrated enteral feeds without free water flushes

Risk factors

›High-risk populations

03Physical Exam/exam51

Vitals and general appearance

›Hemodynamic status

›Heart rate

›Tachycardia indicates hypovolemia

›Orthostatic increase >= 20 bpm

›Blood pressure

›Orthostatic drop >= 20 mmHg systolic

›Frank hypotension in severe hypovolemia

›Temperature

›Fever both a cause and consequence

›Insensible losses increase with each degree above 37 C

›General appearance

›Agitation or restlessness

›Early neurologic sign

›May precede obtundation

›Weight compared to recent baseline

›Acute weight loss reflects fluid deficit

›1 kg loss approximates 1 litre of free water deficit

Neurologic exam

›Level of consciousness correlation

›Mild Na 146 to 150 mmol/l

›Usually asymptomatic or mild fatigue

›Nonspecific weakness

›Moderate Na 151 to 159 mmol/l

›Lethargy and confusion

›Nausea and vomiting

›Severe Na >= 160 mmol/l

›Obtundation, seizures, coma

04Differential Diagnosis/ddx52

Water deficit etiologies

›Inadequate intake

›Impaired thirst mechanism

›ICD-10 R63.1 — polydipsia absent

›Hypothalamic lesion — adipsic hypernatremia

›Restricted access

›Physical disability

›Elder neglect

›Most common overall cause in community and hospital settings

›History usually diagnostic

›Renal water losses

›Central diabetes insipidus

›ICD-10 E23.2

›ADH deficiency from hypothalamic or pituitary pathology

›Urine osmolality < 300 mOsm/kg despite dehydration

›Nephrogenic diabetes insipidus

›ICD-10 N25.1

›Renal ADH resistance

›Lithium commonest drug cause

›Osmotic diuresis

›Hyperglycemia — DKA or HHS

›Mannitol administration

›Urea excretion in high-protein tube feeds

Extrarenal losses and iatrogenic causes

›GI losses

›Diarrhea — osmotic or secretory

›Hypotonic stool losses

›Lactulose-related

05Laboratory Tests/lt52

Core electrolyte and osmolality panel

›Serum sodium

›Confirms diagnosis > 145 mmol/l

›Mild 146 to 150 mmol/l

›Moderate 151 to 159 mmol/l

›Severe >= 160 mmol/l

›Corrected sodium in hyperglycemia

›Add 1.6 mmol/l per 5.6 mmol/l glucose above 5.6 mmol/l

›Serum osmolality

›Elevated > 295 mOsm/kg confirms hyperosmolality

›Calculated: 2 x Na + glucose/18 + BUN/2.8

›Osmol gap if measured exceeds calculated by > 10

›BMP or CMP

›Potassium

›Hypokalemia common with diuretic causes

›Hyperkalemia with adrenal insufficiency

›Glucose

›Osmotic diuresis threshold assessment

›Corrected sodium calculation input

›BUN and creatinine

›Pre-renal AKI from dehydration

›BUN:creatinine ratio > 20 suggests prerenal

Urine studies

›Urine osmolality — key diagnostic discriminator

›> 800 mOsm/kg

›Appropriate renal concentration

›Extrarenal losses or inadequate intake

›< 300 mOsm/kg

06Diagnostic Tests/dt72

Scoring Systems

›Severity classification system

›Mild hypernatremia — Na 146 to 150 mmol/l

›Usually asymptomatic

›Oral hydration typically sufficient

›Moderate hypernatremia — Na 151 to 159 mmol/l

›Neurologic symptoms common

›IV correction often required

›Severe hypernatremia — Na >= 160 mmol/l

›High mortality risk

›ICU-level monitoring required

›Free water deficit calculation

›FWD (L) = TBW x (serum Na / 140 - 1)

›TBW = 0.6 x weight kg for adult males

›TBW = 0.5 x weight kg for adult females

›TBW = 0.45 to 0.5 x weight kg for elderly

›Account for ongoing losses in addition to calculated deficit

›Insensible losses 500 to 800 ml/day

›Urinary losses vary by etiology

›ACEP guidance

›No specific ACEP guidelines for hypernatremia alone

›Management guided by nephrology and endocrinology society standards

›AHA/ACC electrolyte management frameworks applicable

MRI

›Brain MRI indications

›Central diabetes insipidus workup

›Pituitary and hypothalamic evaluation

›Bright spot of posterior pituitary may be absent in central DI

07Disposition/dispo41

Admission criteria

›Inpatient admission indications

›Severity-based

›Na >= 150 mmol/l with symptoms

›Any neurologic manifestations including confusion

›Hemodynamic instability or significant volume depletion

›Clinical status

›Unable to tolerate oral fluids

›Requires IV correction

›Unclear etiology requiring inpatient workup

›Underlying condition

›Requiring inpatient management

›Active infectious precipitant

ICU and high-dependency criteria

›ICU admission triggers

›Na >= 160 mmol/l with altered mental status

›Seizures or coma

›Requires frequent q2 to q4 hour sodium monitoring

›Hemodynamic instability

›Vasopressor requirement

›Aggressive resuscitation needed

›Ongoing seizure activity

›Antiepileptic management complexity

›Airway monitoring

›Step-down eligibility

›Na trending toward normal with stable neurology

›Tolerating PO or enteral fluids

›Reliable monitoring achievable on floor

08Treatment/t86

Initial resuscitation and volume restoration

›Hemodynamically unstable patients

›Isotonic saline 0.9% NaCl first

›Restore perfusion before free water correction

›500 ml to 1 litre bolus IV over 30 minutes

›Reassess hemodynamics and urine output

›Transition to hypotonic fluids once stable

›Avoid prolonged isotonic saline — will worsen hypernatremia

›Switch to D5W or 0.45% NaCl after perfusion restored

Free water deficit replacement

›Fluid selection

›D5W — preferred IV option for pure free water replacement

›1 litre D5W provides approximately 1 litre of free water

›Glucose metabolized rapidly leaving free water

›0.45% NaCl (half-normal saline)

›Provides approximately 500 ml free water per litre

›Option when some sodium replacement also required

›0.2% NaCl (quarter-normal saline)

›Higher free water content than 0.45% NaCl

›Useful in moderate to severe cases

›Oral or enteral free water — preferred when feasible

›Safest route for alert cooperative patients

›Avoid isotonic saline — worsens hypernatremia

›Correction rate targets

›Acute hypernatremia < 48 hours

›Up to 1 mmol/l per hour

›Cerebral adaptation has not occurred

›Chronic or unknown duration > 48 hours

›No faster than 10 mmol/l per 24 hours

›More recent evidence supports up to 12 mmol/l per 24 hours in adults

›2025 meta-analysis: faster correction appears safe in adults without neurologic complications when < 1 mmol/l per hour

›Infants — most conservative rate

›No faster than 0.5 mmol/l per hour

›Maximum 12 mmol/l per 24 hours

›Higher cerebral edema risk

Rate calculation and monitoring

›Infusion rate calculation

›Calculate free water deficit using Adrogue-Madias formula

›FWD = TBW x (serum Na / 140 - 1)

›TBW male = 0.6 x weight kg

›TBW female = 0.5 x weight kg

›Add daily insensible losses 500 to 800 ml/day

›Add ongoing urinary and GI losses

›Total fluid to replace over 24 to 48 hours based on target rate

›Monitoring protocol

›Serum sodium every 4 to 6 hours during active correction

›Adjust infusion rate based on each result

›Do not rely on calculated rates alone

›Urine output monitoring

›Hourly urine output target > 0.5 ml/kg/hour

›High output suggests ongoing DI — increase free water input

›Neurologic reassessment with each sodium check

›Improvement expected

›Deterioration with falling Na suggests cerebral edema

Diabetes insipidus-specific treatment

›Central diabetes insipidus

›Desmopressin (DDAVP)

›Intranasal: 10 to 40 mcg daily in 1 to 2 divided doses

›IV or SC: 1 to 4 mcg every 12 to 24 hours

›Titrate to urine output < 200 ml/hour

›Monitor for hyponatremia with overcorrection

›Mechanism

›Synthetic ADH analogue

›Binds V2 receptor in collecting duct

›Nephrogenic diabetes insipidus

›Remove causative agent if possible

›Discontinue lithium — renal function may improve slowly

›Correct hypercalcemia or hypokalemia

›Thiazide diuretics — paradoxical effect

›Hydrochlorothiazide 25 to 50 mg daily

›Volume depletion increases proximal reabsorption reducing distal delivery

›NSAIDs adjunct

›Indomethacin 25 to 50 mg three times daily

›Reduces prostaglandin-mediated ADH antagonism

›Low-sodium diet and low-protein diet reduce osmotic load

Seizure and complication management

›Acute seizure management

›Lorazepam 2 to 4 mg IV

›First-line benzodiazepine

›Repeat in 5 minutes if no response

›Levetiracetam IV as second-line

›1000 to 3000 mg IV over 15 minutes

›Avoid phenytoin — limited efficacy in metabolic seizures

›Definitive treatment is sodium correction — anticonvulsants adjunctive only

›Cerebral edema from overcorrection

›Hypertonic saline 3% NaCl

›100 to 150 ml IV over 15 to 30 minutes

›Raises serum sodium to reverse acute edema

›Repeat if needed based on neurologic response

›Slow the free water infusion rate

›Allow sodium to stabilize before resuming correction

09Special Populations/sp70

Pregnancy

›Physiologic context

›Plasma volume expansion of 40 to 50% in normal pregnancy

›Serum sodium normally 4 to 5 mmol/l lower than non-pregnant

›Osmotic threshold for thirst and ADH release is reduced

›Increased free water clearance

›Vasopressinase enzyme from placenta degrades ADH

›Gestational diabetes insipidus in third trimester

›Management considerations

›Fluid selection safety

›D5W considered safe in pregnancy for free water replacement

›Monitor fetal heart rate during IV correction

›Desmopressin in pregnancy

›Resistant to vasopressinase unlike natural ADH

›First-line for gestational central DI

›No teratogenic risk established — Category B equivalent

›Correction rate

›Apply same principles as non-pregnant adults

›Neonatal risk if maternal sodium corrected too rapidly near delivery

Geriatric

›Physiologic vulnerabilities

›Blunted thirst mechanism with aging

›Absent or markedly reduced thirst despite high osmolality

›Most common population for community-acquired hypernatremia

›Reduced TBW

›TBW 0.45 to 0.5 x weight kg in elderly

›Less free water buffer for osmotic stress

›Impaired renal concentrating ability

10Background/b75

Epidemiology

›Prevalence and incidence

›Emergency department prevalence

›1 to 2% of ED presentations

›Higher rates in elderly patients

›ICU prevalence

›Up to 10% in ICU settings

›Hospital-acquired hypernatremia associated with higher mortality

›Mortality data

›Highest mortality of any electrolyte disorder

›In-hospital mortality 40 to 60% in severe ICU hypernatremia

›Mortality reflects severity of underlying illness not sodium alone

›Risk population distribution

›Community-acquired hypernatremia

›Predominantly elderly with impaired access or thirst

›Nursing home residents

›Hospital-acquired hypernatremia

›Inappropriate IV fluids with high sodium content

›Inadequate free water with enteral nutrition

›Sedated or intubated patients unable to drink

Pathophysiology

›Osmolality and water regulation

›Normal serum osmolality 275 to 295 mOsm/kg

›Hypernatremia implies hyperosmolality in nearly all cases

›Osmoreceptors in hypothalamus respond to 1 to 2% change

›ADH axis

›Osmoreceptor activation triggers ADH release from posterior pituitary

›ADH acts on V2 receptors in collecting duct

›Aquaporin-2 channels inserted — free water reabsorption

›Thirst mechanism

›Osmolality > 295 mOsm/kg triggers thirst

›Primary defense against hypernatremia in ambulatory patients

›Brain adaptation

›Acute hypernatremia

›Brain shrinks as water moves to hyperosmolar plasma

›Tearing of bridging veins — subarachnoid and subdural hemorrhage

›Chronic hypernatremia

›Brain accumulates idiogenic osmoles within 24 to 48 hours

›Restores brain volume toward normal

›Rapid correction removes plasma osmolality without removing idiogenic osmoles

›Net water shift into brain — cerebral edema risk

›Classification by volume status

›Hypovolemic hypernatremia

›Total body sodium decreased but water loss greater

›Extrarenal or renal losses with insufficient replacement

›Euvolemic hypernatremia

›Normal total body sodium with pure water deficit

›Diabetes insipidus or insensible loss dominant

›Hypervolemic hypernatremia

›Both sodium and water increased but sodium gain exceeds water gain

›Iatrogenic — hypertonic saline or sodium bicarbonate

Therapeutic Considerations

›Evidence base for correction rate

›Classic recommendation

›No faster than 10 mmol/l per 24 hours for chronic hypernatremia

›Based on risk of cerebral edema from idiogenic osmole accumulation

›Emerging evidence — 2023 cohort (Feigin et al, JAMA Network Open)

›Faster correction > 0.5 mmol/l per hour associated with improved survival

›No increase in neurologic complications in adults

›2025 meta-analysis (Kitisin et al, Journal of Critical Care)

›Faster correction appears safe and may benefit severe hypernatremia

›No major neurological complications when rate < 1 mmol/l per hour

›Most benefit in first 24 hours of admission

›Fluid strategy considerations

›Oral and enteral route first choice

›Lower risk of overcorrection

›Physiologic rate of absorption limits speed

›IV D5W provides most free water per litre

›Must account for glucose effect in diabetics

›Monitoring is non-negotiable regardless of route

›Calculate does not equal achieve

›Serum sodium every 4 to 6 hours mandatory

›ICD-10 coding

›E87.0 — Hyperosmolality and hypernatremia

›Primary coding for hypernatremia

›E23.2 — Diabetes insipidus (central)

›N25.1 — Nephrogenic diabetes insipidus

›E86.0 — Dehydration

11Patient Discharge Instructions/pdi26

copy discharge instructions

›Discharge instructions for Hypernatremia

›Your sodium level was high — this is called hypernatremia

›This happens when you do not drink enough fluid or lose too much water

›Your body's water and salt balance needs to be maintained daily

›Hydration instructions

›Drink at least 2 to 3 litres of water or non-caffeinated fluids daily

›If you use tube feeds, make sure you are receiving adequate free water flushes

›Set regular reminders to drink if you do not feel thirsty

›Return to emergency department immediately if you experience

›New or worsening confusion or difficulty thinking clearly

›Seizure or loss of consciousness

›Inability to drink fluids or persistent vomiting

›Decreased urine output or no urine for 8 hours

›Extreme weakness or inability to move normally

›Medications

›Take all medications as prescribed

›Do not stop or restart diuretics (water pills) without speaking to your doctor

›If prescribed desmopressin, take at the same time daily

›Follow-up

›See your family doctor within 1 to 3 days

›A repeat blood sodium test will be needed at that visit

›Report any new symptoms between now and your follow-up appointment

›Caregivers and family members

›Ensure the patient has access to fluids at all times

›Offer fluids regularly — especially in hot weather or during illness

›Contact your doctor if the patient is not eating or drinking normally

12References/r30

Guidelines and key sources

›Primary references

›Miller NE, Rushlow D, Stacey SK — Diagnosis and Management of Sodium Disorders: Hyponatremia and Hypernatremia — American Family Physician 2023

›PMID 37983699

›Comprehensive review of causes, diagnosis, and management

›Drummond JB et al — Pathophysiology and Aetiologies of Hypernatremia — Best Practice and Research Clinical Endocrinology and Metabolism 2025

›PMID 41176477

›Current mechanistic review

›Tomkins M et al — Diagnosis and Treatment of Hypernatremia — Best Practice and Research Clinical Endocrinology and Metabolism 2025

›PMID 41203493

›Treatment protocols and evidence review

›Landmark studies

›Adrogue HJ, Madias NE — Hypernatremia — New England Journal of Medicine 2000

›Foundation for free water deficit formula and correction principles

›Sterns RH — Disorders of Plasma Sodium — New England Journal of Medicine 2015

›Comprehensive osmotic demyelination and correction rate evidence

›Feigin E et al — Rate of Correction and All-Cause Mortality in Patients With Severe Hypernatremia — JAMA Network Open 2023

›Cohort demonstrating safety of faster correction rates

›Kitisin N et al — Systematic Review and Meta-Analysis of the Treatment of Hypernatremia in Adult Hospitalized Patients — Journal of Critical Care 2025

›PMID 39765195

›2025 meta-analysis confirming faster correction safety

›Additional sources

›Arora SK — Hypernatremic Disorders in the Intensive Care Unit — Journal of Intensive Care Medicine 2011

›PMID 21576189

›ICU-specific management and complications

›Brennan M et al — Approach to the Management of Hypernatraemia in Older Hospitalised Patients — Journal of Nutrition Health and Aging 2021

›PMID 34866143

›Geriatric-specific guidance

Learn More: Hypernatremia→

Comprehensive Clinical Review

Structured, evidence-informed, long-form analysis for deeper understanding.

Evidence & Review

Reviewed by SymptomDx Medical Team · Last reviewed August 18, 2026

SymptomDx is an educational tool for medical professionals. It does not replace clinical judgment. Verify all clinical data and drug dosages with authoritative sources.